Boundless Bio, Common Stock Today
| BOLD Stock | USD 11.46 0.18 1.55% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Boundless Bio, is trading at 11.46 as of the 30th of April 2024, a -1.55 percent decrease since the beginning of the trading day. The stock's lowest day price was 10.86. Boundless Bio, has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Boundless Bio, Common are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of March 2024 and ending today, the 30th of April 2024. Click here to learn more.
IPO Date 28th of March 2024 | Category Healthcare |
Audentes Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases caused by single gene defects. Audentes Therapeutics, Inc. The company has 22.24 M outstanding shares of which 513.7 K shares are currently shorted by private and institutional investors with about 0.0 trading days to cover. More on Boundless Bio, Common
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Boundless Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Boundless Bio,'s investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Boundless Bio, or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Matthew Patterson | |||||||||||||||||||||||||||||||||||||||||||||
| Old Name | 21S BOLD | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Boundless Bio, report their recommendations after researching Boundless Bio,'s financial statements, talking to executives and customers, or listening in on Boundless Bio,'s conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Boundless Bio, Common. The Boundless consensus assessment is calculated by taking the average forecast from all of the analysts covering Boundless Bio,. | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key measurements obtained from Boundless Bio,'s financial statements, Boundless Bio, Common may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Boundless Bio, Common is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||
Boundless Bio,'s financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Boundless Bio,'s success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Boundless Bio,'s financial leverage. It provides some insight into what part of Boundless Bio,'s total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Boundless Bio, Common (BOLD) is traded on NASDAQ Exchange in USA. It is located in 9880 Campus Point Drive, San Diego, CA, United States, 92121 and employs 72 people. Boundless Bio, is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 301.12 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Boundless Bio,'s market, we take the total number of its shares issued and multiply it by Boundless Bio,'s current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Boundless Bio, Common conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 22.24 M outstanding shares of which 513.7 K shares are currently shorted by private and institutional investors with about 0.0 trading days to cover.
Boundless Bio, Common currently holds about 351.46 M in cash with (46.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.68.
Check Boundless Bio, Probability Of Bankruptcy
Ownership AllocationBoundless Bio, Common retains a total of 22.24 Million outstanding shares. 30% of Boundless Bio, Common outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Boundless Ownership Details
Boundless Stock Price Odds Analysis
What are Boundless Bio,'s target price odds to finish over the current price? Based on a normal probability distribution, the odds of Boundless Bio, jumping above the current price in 90 days from now is about 63.67%. The Boundless Bio, Common probability density function shows the probability of Boundless Bio, stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Boundless Bio, Common has a beta of -0.0049 suggesting as returns on the benchmark increase, returns on holding Boundless Bio, are expected to decrease at a much lower rate. During a bear market, however, Boundless Bio, Common is likely to outperform the market. Additionally, boundless Bio, Common has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Boundless Bio, to move above the current price in 90 days from now is about 63.67 (This Boundless Bio, Common probability density function shows the probability of Boundless Stock to fall within a particular range of prices over 90 days) .
Boundless Bio, Historical Income Statement
Boundless Bio, Common Income Statement is one of the three primary financial statements used for reporting Boundless's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Boundless Bio, Common revenue and expense. Boundless Bio, Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Boundless Bio,'s Research Development is projected to decrease significantly based on the last few years of reporting. The current year's Total Operating Expenses is expected to grow to about 55.2 M, whereas Selling General Administrative is forecasted to decline to about 11.5 M. View More FundamentalsBoundless Stock Against Markets
Picking the right benchmark for Boundless Bio, stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Boundless Bio, stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Boundless Bio, is critical whether you are bullish or bearish towards Boundless Bio, Common at a given time. Please also check how Boundless Bio,'s historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Boundless Bio, without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Boundless Bio, Corporate Directors
Boundless Bio, corporate directors refer to members of a Boundless Bio, board of directors. The board of directors generally takes responsibility for the Boundless Bio,'s affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Boundless Bio,'s board members must vote for the resolution. The Boundless Bio, board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Andrew Chang | Director, Investor Relations | Profile | |
| Thomas Woiwode | Independent Director | Profile | |
| Jennifer Jarrett | Director | Profile | |
| Stephen Squinto | Independent Director | Profile |
How to buy Boundless Stock?
Before investing in Boundless Bio,, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Boundless Bio,. To buy Boundless Bio, stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Boundless Bio,. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Boundless Bio, stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Boundless Bio, Common stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Boundless Bio, Common stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Boundless Bio, Common, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Boundless Stock please use our How to Invest in Boundless Bio, guide.
Already Invested in Boundless Bio, Common?
The danger of trading Boundless Bio, Common is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Boundless Bio, is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Boundless Bio,. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Boundless Bio, Common is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Boundless Bio, Common is a strong investment it is important to analyze Boundless Bio,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Boundless Bio,'s future performance. For an informed investment choice regarding Boundless Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boundless Bio, Common. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Boundless Stock analysis
When running Boundless Bio,'s price analysis, check to measure Boundless Bio,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boundless Bio, is operating at the current time. Most of Boundless Bio,'s value examination focuses on studying past and present price action to predict the probability of Boundless Bio,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boundless Bio,'s price. Additionally, you may evaluate how the addition of Boundless Bio, to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Boundless Bio,'s industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boundless Bio,. If investors know Boundless will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boundless Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (0.33) | Return On Equity (0.53) |
The market value of Boundless Bio, Common is measured differently than its book value, which is the value of Boundless that is recorded on the company's balance sheet. Investors also form their own opinion of Boundless Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Boundless Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boundless Bio,'s market value can be influenced by many factors that don't directly affect Boundless Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boundless Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Boundless Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boundless Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.